| Original language | English |
|---|---|
| Pages (from-to) | 1609-1610 |
| Number of pages | 2 |
| Journal | Annals of Oncology |
| Volume | 20 |
| Issue number | 9 |
| DOIs | |
| State | Published - 2009 |
| Externally published | Yes |
Fingerprint
Tonsillar Neoplasms
Aseptic Meningitis
Diphenhydramine
Anti-Allergic Agents
Laryngeal Neoplasms
Premedication
Antineoplastic Agents
Dexamethasone
Squamous Cell Carcinoma
Anti-Inflammatory Agents
Monoclonal Antibodies
Cetuximab
ASJC Scopus subject areas
- Oncology
- Hematology
Cite this
Feinstein, T. M., Gibson, M. K., & Argiris, A. (2009). Cetuximab-induced aseptic meningitis. Annals of Oncology, 20(9), 1609-1610. https://doi.org/10.1093/annonc/mdp382
Cetuximab-induced aseptic meningitis. / Feinstein, T. M.; Gibson, M. K.; Argiris, A.
In: Annals of Oncology, Vol. 20, No. 9, 2009, p. 1609-1610.Research output: Contribution to journal › Article
Feinstein, TM, Gibson, MK & Argiris, A 2009, 'Cetuximab-induced aseptic meningitis', Annals of Oncology, vol. 20, no. 9, pp. 1609-1610. https://doi.org/10.1093/annonc/mdp382
Feinstein TM, Gibson MK, Argiris A. Cetuximab-induced aseptic meningitis. Annals of Oncology. 2009;20(9):1609-1610. https://doi.org/10.1093/annonc/mdp382
@article{f2f3c7f7125b400da3e872458ecb582e,
title = "Cetuximab-induced aseptic meningitis",
author = "Feinstein, {T. M.} and Gibson, {M. K.} and A. Argiris",
year = "2009",
doi = "10.1093/annonc/mdp382",
language = "English",
volume = "20",
pages = "1609--1610",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "9",
}
TY - JOUR
T1 - Cetuximab-induced aseptic meningitis
AU - Feinstein, T. M.
AU - Gibson, M. K.
AU - Argiris, A.
PY - 2009
Y1 - 2009
UR - http://www.scopus.com/inward/record.url?scp=69849111028&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=69849111028&partnerID=8YFLogxK
U2 - 10.1093/annonc/mdp382
DO - 10.1093/annonc/mdp382
M3 - Article
C2 - 19643807
AN - SCOPUS:69849111028
VL - 20
SP - 1609
EP - 1610
JO - Annals of Oncology
JF - Annals of Oncology
SN - 0923-7534
IS - 9
ER -